Min Seo

Min Seo has worked in a variety of roles in the healthcare industry. Min began their career in 2008 as a Management Consultant at Monitor Deloitte (ex Monitor Group). In 2016, they moved to Gilead Sciences, where they served as Director, Global Commercial Strategy & Operations. In 2019, they were hired as Director Commercial Strategy at Forty Seven Inc. (Acquired by Gilead in April 2020). In 2020, they took on the role of Senior Director, Head of Commercial Planning and Business Analytics at Assembly Biosciences, Inc. and is currently serving as Senior Director, Commercial and Business Strategy at Asher Biotherapeutics.

Min Seo holds a Ph.D in Chemical/Bio Engineering from The University of Texas at Austin and a Bachelor of Science summa cum laude in Chemical Engineering from Pohang University of Science and Technology.